Humana trades near fair value, reflecting a mixed profit outlook and Medicare Advantage uncertainties. Click here to read an analysis of HUM stock now.

Humana Inc. HUM has tested investor conviction over the past year as rising medical costs, reimbursement uncertainty, and ...

Humana stock was falling after the healthcare insurer announced the retirement of its current insurance president and reiterated guidance for this year. Humana shares were down 2.5% in premarket ...

Humana's margins have declined due to rising policy benefits, high medical loss ratios, and increased utilization ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $170.0 to $360.0 for Humana over the last 3 months.

Humana is ramping up its focus on primary care. The insurer plans to shell out between $450 million and $550 million to buy the first group of senior-focused primary care centers it built through a ...

Humana CFO Susan Diamond told investors on Wednesday that the insurer is likely to lose a "few hundred thousand members" as it adjusts to ongoing pressures in the Medicare Advantage space. On its ...

Humana is sketching out expansion plans for its fledgling primary care network, announcing Wednesday that its CenterWell and Conviva brands expect to add up to 30 new centers this year. The new ...

George Renaudin, who has been with Humana for almost 30 years, is retiring, the insurer announced Tuesday. Aaron Martin, previously Amazon’s vice president of healthcare, will take his place.

Humana said it is investing $100 million in the in-home primary care company, Heal, to bring in-person physician “house calls and one-touch medicine” to seniors in its Medicare Advantage plans.